WALL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced that CRN^�, a brand of The Channel Company, has named Kimberly Biddings, VP of Product, to its industry-recognized and highly respected Women of the Channel list for the second year in a row. This list honors the incredible accomplishments of female leaders in the IT channel whose vision, expertise, and contributions make an impact on the industry every day.

Kimberly is among 100 women being honored for their constant dedication to channel excellence. These extraordinary women bring innovative concepts, strategic business planning and comprehensive channel initiatives to life, while supporting partners and customers with exceptional leadership.

As VP of Product, Kimberly is responsible for all aspects of marketing, including channel marketing. Her focus on the channel includes recruiting, nurturing, and collaborating with BIO-key�s Channel Alliance Partner (CAP) Program relationships. Her channel accomplishments include the successful recruitment and onboarding of new channel partners, value added distributors, and master agents, enabling channel sales teams to expand BIO-key�s global footprint, and working with partners on co-branded marketing activities. With over 10 years� experience of channel-first thinking in the cybersecurity and IAM industry, she brings strong market knowledge and experience from her tenure at multiple authentication and cybersecurity firms to all BIO-key�s channel relationships.

�We are proud to once again recognize the remarkable leaders on this year�s Women of the Channel list. Their influence, confidence, and diligence continue to accelerate channel success significantly,� said Blaine Raddon, CEO of The Channel Company. �Their accomplishments will inspire others, and we look forward to witnessing their future contributions to the channel.�

�Kimberly�s leadership of product and brand marketing has been critical in driving growth and expanding BIO-key�s CAP Program,� said Fred Corsentino, Chief Revenue Officer, and head of the CAP Program at BIO-key. �She has spearheaded channel initiatives to evangelize the additional revenue opportunities of BIO-key�s Identity-Bound Biometrics and PortalGuard platform, showcasing her results and mission-driven mindset through the quality of her contributions to our channel relationships.�

CRN�s 2022 Women of the Channel list is being featured in the June 2022 issue of CRN Magazine and online at�www.CRN.com/WOTC. To learn more about Kimberly and BIO-key please visit the BIO-key website.

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor Identity and Access Management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry leading biometric capabilities, enable large-scale on-premises and cloud-based Identity-as-a-Service (IDaaS) solutions, as well as customized enterprise solutions.

About The Channel Company

The Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers, and end-users. Backed by more than 30 years of unequaled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace.�www.thechannelcompany.com

Follow The Channel Company:�Twitter,�LinkedIn, and�Facebook.

� 2022. CRN is a registered trademark of The Channel Company, LLC. All rights reserved.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K for the year ended December 31, 2021 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

Engage with BIO-key
Facebook � Corporate: https://www.facebook.com/BIOkeyInternational/
LinkedIn � Corporate: https://www.linkedin.com/company/bio-key-international
Twitter � Corporate: @BIOkeyIntl
Twitter � Investors: @BIO_keyIR
StockTwits: BIO_keyIR

Media Contact
Erin Knapp
Matter on behalf of BIO-key
[email protected]

Investor Contacts
William Jones, David Collins
Catalyst IR
[email protected]
212-924-9800

The Channel Company Contact:
Jennifer Hogan
The Channel Company
[email protected]